InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Laura Shawver, Director, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 22 open-market SEC Form 4 transactions: 0 purchases worth $0 and 22 sales worth $8.6M, reported from Nov 9, 22 to Apr 7, 25. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 7, 25 | SPRYARS Pharmaceuticals, Inc. | SELL | 50.0K | $12.30 | $615K |
| Mar 6, 25 | SPRYARS Pharmaceuticals, Inc. | SELL | 49.6K | $11.21 | $556K |
| Mar 5, 25 | SPRYARS Pharmaceuticals, Inc. | SELL | 400 | $11.00 | $4K |
| Feb 3, 25 | SPRYARS Pharmaceuticals, Inc. | SELL | 50.0K | $12.31 | $616K |
| Jan 6, 25 | SPRYARS Pharmaceuticals, Inc. | SELL | 50.0K | $11.10 | $555K |
| Dec 4, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 14.8K | $13.75 | $203K |
| Dec 3, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 88.0K | $13.26 | $1.2M |
| Dec 2, 24 | SPRYARS Pharmaceuticals, Inc. | SELL | 96.3K | $14.34 | $1.3M |
| Sep 1, 23 | SPRYARS Pharmaceuticals, Inc. | SELL | 100.0K | $7.71 | $771K |
| Aug 4, 23 | SPRYARS Pharmaceuticals, Inc. | SELL | 18.9K | $7.06 | $133K |
| Aug 3, 23 | SPRYARS Pharmaceuticals, Inc. | SELL | 26.1K | $7.01 | $183K |
| Aug 2, 23 | SPRYARS Pharmaceuticals, Inc. | SELL | 36.3K | $7.09 | $257K |
| Aug 1, 23 | SPRYARS Pharmaceuticals, Inc. | SELL | 18.7K | $7.19 | $135K |
| Jul 7, 23 | SPRYARS Pharmaceuticals, Inc. | SELL | 8.9K | $6.36 | $56K |
| Jul 6, 23 | SPRYARS Pharmaceuticals, Inc. | SELL | 33.5K | $6.34 | $212K |
| Jul 5, 23 | SPRYARS Pharmaceuticals, Inc. | SELL | 31.1K | $6.41 | $199K |
| Jul 3, 23 | SPRYARS Pharmaceuticals, Inc. | SELL | 26.5K | $6.73 | $178K |
| Jun 2, 23 | SPRYARS Pharmaceuticals, Inc. | SELL | 26.9K | $6.95 | $187K |
| Jun 1, 23 | SPRYARS Pharmaceuticals, Inc. | SELL | 73.1K | $6.80 | $497K |
| May 9, 23 | SPRYARS Pharmaceuticals, Inc. | SELL | 42.9K | $5.31 | $228K |
| May 8, 23 | SPRYARS Pharmaceuticals, Inc. | SELL | 57.1K | $6.16 | $352K |
| Nov 9, 22 | SPRYARS Pharmaceuticals, Inc. | SELL | 43.9K | $4.58 | $201K |